HUMA THERAPEUTICS LIMITED
Get an alert when HUMA THERAPEUTICS LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-29 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-12-09 (in 7mo)
Last made up 2025-11-25
Watchouts
Cash
£12M
+3.3% vs 2023
Net assets
£71M
-12.5% vs 2023
Employees
337
-9.2% vs 2023
Profit before tax
-£29M
+48.9% vs 2023
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Audit opinion: Qualified
Latest auditor's report carried a non-clean opinion.
Net assets
7-year trend · vs Telecommunications median
Accounts
7-year trend · latest reflected 2024-12-31
| Metric | Trend | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Turnover | — | — | — | — | — | £30,695,000 | £30,074,000 | |
| Operating profit | — | — | — | — | — | -£56,281,000 | -£29,186,000 | |
| Profit before tax | — | — | — | -£28,112,000 | — | -£56,067,000 | -£28,664,000 | |
| Net profit | — | — | — | — | — | -£53,046,000 | -£28,780,000 | |
| Cash | — | — | £5,248,000 | £44,407,000 | — | £11,549,000 | £11,933,000 | |
| Total assets less current liabilities | — | — | — | — | — | £86,854,000 | £75,951,000 | |
| Net assets | — | — | — | — | — | £81,544,000 | £71,387,000 | |
| Equity | £32,489,000 | £22,370,000 | £21,284,000 | £73,991,000 | -£99,750,000 | £81,544,000 | £71,387,000 | |
| Average employees | — | — | — | 170 | — | 371 | 337 | |
| Wages | — | — | — | — | — | £31,766,000 | £20,138,000 | |
| Directors' remuneration | — | — | — | — | — | £160,000 | £139,000 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
-2%
£30,695,000 £30,074,000
-
Cash
+3.3%
£11,549,000 £11,933,000
-
Net assets
-12.5%
£81,544,000 £71,387,000
-
Employees
-9.2%
371 337
-
Operating profit
+48.1%
-£56,281,000 -£29,186,000
-
Profit before tax
+48.9%
-£56,067,000 -£28,664,000
-
Wages
-36.6%
£31,766,000 £20,138,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Operating margin | — | — | — | — | — | -183.4% | -97.0% | |
| Net margin | — | — | — | — | — | -172.8% | -95.7% | |
| Return on capital employed | — | — | — | — | — | -64.8% | -38.4% | |
| Gearing (liabilities / total assets) | — | — | — | — | — | 18.7% | 26.5% | |
| Current ratio | — | — | — | — | — | 3.00x | 1.81x | |
| Interest cover | — | — | — | — | — | -157.21x | -208.47x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 2 times since incorporation
- HUMA THERAPEUTICS LIMITED 2020-04-17 → present
- HUMAFORHEALTH LIMITED 2020-04-16 → 2020-04-17
- MEDOPAD LTD 2011-08-02 → 2020-04-16
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Consolidated group
- Auditor
- Gravita Audit II Limited
- Audit opinion
- Qualified
- Going concern
- Affirmed
“The directors have a reasonable expectation that the Group has adequate resources to continue in operational existence for the foreseeable future. Accordingly they continue to adopt the going concern basis of accounting in preparing the annual financial statements.”
Group structure
- HUMA THERAPEUTICS LIMITED · parent
- Medopad Inc. 100%
- Medopad Information Technology (Shanghai) Co., Ltd. 100%
- Huma Therapeutics GmbH 100%
- Iplato Limited 100%
- Iplato Healthcare Limited 100%
- Iplato s.r.o 100%
- Alcedis GmbH 100%
- TheraOp GmbH 100%
- eConsult Health Limited 100%
- MyMed Ltd 100%
Significant events
- “In 2024 Huma acquired eConsult Health Limited one of the largest digital-first triage and automated consultation platforms across primary and emergency care in the UK. 2024 also saw the launch of Huma Cloud Platform and Huma Workspace for Health systems enabling healthcare providers, Life Science companies and other industry players access to a comprehensive array of digital health solutions.”
- “Post year end, the subsidiary Huma Therapeutics GmbH was formally dissolved.”
- “The Company has acquired the assets of Know Medical Diagnostics Inc ("Aluna") and MJOG Limited.”
- “In March 2025, 2,185 D1 Preference shares of £0.001 each were allotted as fully paid at a premium of £18.20 per share.”
- “In April 2025, 743,000 Ordinary shares of £0.001 each were allotted as fully paid at a premium of £17.47 por share.”
- “In May 2025 the company entered into a new lease agreement commencing September 2025 to December 2027 with yearly rent of £180,000.”
- “In September 2025, the Company entered in to a $5m, zero-interest, 3 year convertible loan arrangement with Sicpa SA, which is anticipated to immediately convert to equity.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 6 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| KHATIB, Rich, Dr | Director | 2012-08-01 | Dec 1964 | British |
| MALEKI, Eskandar | Director | 2018-03-07 | Dec 1950 | Austrian |
| VAHDAT, Danoosh | Director | 2012-08-01 | Aug 1984 | British |
Show 6 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| FLETCHER, Stuart Robert | Director | 2017-12-27 | 2023-10-17 |
| MACKINNON, Simon John | Director | 2017-10-25 | 2020-09-23 |
| MILBURN, Alan | Director | 2020-04-08 | 2023-10-17 |
| OXLEY, Mark | Director | 2011-08-02 | 2012-08-01 |
| SUESSMUTH-DYCKERHOFF, Claudia Ricarda Rita, Dr | Director | 2021-04-01 | 2023-10-17 |
| @UKPLC CLIENT DIRECTOR LTD | Corporate Director | 2011-08-02 | 2012-08-01 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Mr Danoosh Vahdat | Individual | Appoints directors | 2020-04-09 | Active |
| Mr Danoosh Vahdat | Individual | Shares 25–50%, Voting 25–50% | 2016-05-12 | Ceased 2019-01-17 |
| Dr Rich Khatib | Individual | Shares 25–50%, Voting 25–50% | 2016-05-12 | Ceased 2019-01-17 |
Filing timeline
Last 20 of 172 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-12-10 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-12-01 | PSC04 | persons-with-significant-control | Change to a person with significant control | |
| 2025-10-23 | AA | accounts | Accounts with accounts type group | |
| 2025-07-23 | PSC04 | persons-with-significant-control | Change to a person with significant control | |
| 2025-07-21 | SH01 | capital | Capital allotment shares | |
| 2025-07-21 | SH01 | capital | Capital allotment shares | |
| 2025-04-11 | AA | accounts | Accounts with accounts type group | |
| 2025-03-19 | SH01 | capital | Capital allotment shares | |
| 2025-03-19 | SH01 | capital | Capital allotment shares | |
| 2025-01-30 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2024-12-23 | AA01 | accounts | Change account reference date company previous shortened | |
| 2024-11-26 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-10-04 | SH01 | capital | Capital allotment shares | |
| 2024-10-04 | SH01 | capital | Capital allotment shares | |
| 2024-09-27 | AA01 | accounts | Change account reference date company previous shortened | |
| 2024-04-29 | SH01 | capital | Capital allotment shares | |
| 2024-04-29 | SH01 | capital | Capital allotment shares | |
| 2024-04-15 | RP04CS01 | confirmation-statement | Second filing of confirmation statement with made up date | |
| 2024-04-15 | RP04CS01 | confirmation-statement | Second filing of confirmation statement with made up date | |
| 2023-11-29 | CS01 | confirmation-statement | Confirmation statement with updates |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 6
- Capital events
- 6
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.